{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:23:48Z","timestamp":1791329028486,"version":"4.3.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018712","name":"Iuliu Hagieganu University of Medicine and Pharmacy Department of Cell and Molecular Biology","doi-asserted-by":"publisher","award":["881\/11\/12.01.2022"],"award-info":[{"award-number":["881\/11\/12.01.2022"]}],"id":[{"id":"10.13039\/501100018712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejpb.2026.115061","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:41:29Z","timestamp":1774021289000},"page":"115061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Orodispersible tablets as delivery platform for oral administration of drug-loaded nanoparticles to paediatric patients"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3901-0738","authenticated-orcid":false,"given":"Andreea","family":"Cornil\u0103","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5009-9550","authenticated-orcid":false,"given":"Sonia","family":"Iurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8943-8938","authenticated-orcid":false,"given":"Lucia Ruxandra","family":"Tefas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana-Maria","family":"Muntean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Casian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Maria","family":"Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0360-016X","authenticated-orcid":false,"given":"Lucian Barbu","family":"Tudoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioan","family":"Tomu\u021b\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-2792","authenticated-orcid":false,"given":"Alina Silvia","family":"Porfire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115061_b0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1208\/s12249-016-0558-3","article-title":"Paediatric drug development and formulation design\u2014a European perspective","volume":"18","author":"Van Riet-Nales","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115061_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bcp.12268","article-title":"Formulations for children: problems and solutions","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115061_b0015","article-title":"Evaluating the acceptability, swallowability, and palatability of film-coated mini-tablet formulation in young children: results from an open-label, single-dose, cross-over study","volume":"15","author":"M\u00fcnch","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2015.02.015","article-title":"Orodispersible drug formulations for children and elderly","volume":"75","author":"Slavkova","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115061_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122838","article-title":"Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone","volume":"636","author":"Tranov\u00e1","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0030","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/pharmaceutics14081621","article-title":"Orally dispersible dosage forms for paediatric use: current knowledge and development of nanostructure-based formulations","volume":"14","author":"Cornil\u0103","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0035","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1208\/s12249-018-1035-y","article-title":"Zein as a pharmaceutical excipient in oral solid dosage forms: state of the art and future perspectives","volume":"19","author":"Berardi","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115061_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111538","article-title":"Zein- vs PLGA-based nanoparticles containing rutin: a comparative investigation","volume":"118","author":"Gagliardi","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2026.115061_b0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ijpharm.2019.06.018","article-title":"The use of zein in the controlled release of poorly water-soluble drugs","volume":"566","author":"Tran","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0050","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3390\/polym14112172","article-title":"Zein microparticles and nanoparticles as drug delivery systems","volume":"14","author":"De Marco","year":"2022","journal-title":"Polymers (Basel)."},{"key":"10.1016\/j.ejpb.2026.115061_b0055","article-title":"A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer","volume":"79","author":"Wang","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0060","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.foodhyd.2017.05.039","article-title":"Caseinate-zein-polysaccharide complex nanoparticles as potential oral delivery vehicles for curcumin: effect of polysaccharide type and chemical cross-linking","volume":"72","author":"Chang","year":"2017","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ejpb.2026.115061_b0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.foodchem.2017.02.001","article-title":"Preparation, characterization and stability of curcumin-loaded zein-shellac composite colloidal particles","volume":"228","author":"Sun","year":"2017","journal-title":"Food Chem."},{"key":"10.1016\/j.ejpb.2026.115061_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.130542","article-title":"Fabrication of Zein-Lecithin-EGCG complex nanoparticles: Characterization, controlled release in simulated gastrointestinal digestion","volume":"365","author":"Xie","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.ejpb.2026.115061_b0075","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jddst.2015.06.012","article-title":"Zein nanoparticles for oral folic acid delivery","volume":"30","author":"Pe\u00f1alva","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144140","article-title":"Formulation of pH-responsive nanoparticles using zein\/sodium alginate polymers for enhanced bioavailability of the vitamin D3","volume":"313","author":"Annappa","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115061_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00619-0","article-title":"Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and \u03b2-cell repair of type 2 diabetes mice","volume":"18","author":"Bao","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2026.115061_b0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/pharmaceutics14010039","article-title":"Zein-based nanoparticles as oral carriers for insulin delivery","volume":"14","author":"Reboredo","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0095","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.3390\/pharmaceutics15102431","article-title":"Pediatric drug development: reviewing challenges and opportunities by tracking innovative therapies","volume":"15","author":"Domingues","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121278","article-title":"Transformation of nanoparticles into compacts: a study on PLGA and celecoxib nanoparticles","volume":"611","author":"Li","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejpb.2023.11.004","article-title":"Effect of magnesium stearate solid lipid nanoparticles as a lubricant on the properties of tablets by direct compression","volume":"193","author":"Mart\u00ednez-Acevedo","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejpb.2017.01.022","article-title":"A minitablet formulation made from electrospun nanofibers","volume":"114","author":"Poller","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0115","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s13346-020-00889-z","article-title":"A new dual function orodissolvable\/dispersible meclizine HCL tablet to challenge patient inconvenience: in vitro evaluation and in vivo assessment in human volunteers","volume":"11","author":"Darwesh","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115061_b0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejpb.2017.04.014","article-title":"Instant ODFs \u2013 Development of an intermediate, nanoparticle-based product platform for individualized medication","volume":"126","author":"Steiner","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118955","article-title":"Orodispersible films containing ball milled aripiprazole-poloxamer\u00ae407 solid dispersions","volume":"575","author":"\u0141yszczarz","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/pharmaceutics13010120","article-title":"A potential alternative orodispersible formulation to prednisolone sodium phosphate orally disintegrating tablets","volume":"13","author":"Tawfik","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0135","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/pharmaceutics12050470","article-title":"Electrospun orodispersible films of isoniazid for pediatric tuberculosis treatment","volume":"12","author":"Chachlioutaki","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0140","article-title":"Turning zein-based nanostructures into oral lyophilizates to address paediatric needs","volume":"108","author":"Cornil\u0103","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118593","article-title":"Electrospun amorphous solid dispersions of meloxicam: Influence of polymer type and downstream processing to orodispersible dosage forms","volume":"569","author":"Casian","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0150","first-page":"1917","article-title":"Optimization of chitosan nanoparticles for colon tumors using experimental design methodology, Artif. Cells Nanomed","volume":"44","author":"Jain","year":"2016","journal-title":"Biotechnol"},{"key":"10.1016\/j.ejpb.2026.115061_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123850","article-title":"Microfluidic nanoparticle synthesis for oral solid dosage forms: a step toward clinical transition processes","volume":"652","author":"Morelli","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0160","article-title":"A novel delivery system for enhancing bioavailability of S-adenosyl-l-methionine: pectin nanoparticles-in-microparticles and their in vitro - in vivo evaluation\u2019","volume":"61","author":"Dogan Ergin","year":"2021","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0165","doi-asserted-by":"crossref","first-page":"793","DOI":"10.31925\/farmacia.2025.3.25","article-title":"Formulation development of freeze-dried zein-based nanostructures with loratadine intended for paediatric use","volume":"73","author":"Cornil\u0103","year":"2025","journal-title":"Farmacia"},{"key":"10.1016\/j.ejpb.2026.115061_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116937","article-title":"Fabrication and characterization of zein-alginate oligosaccharide complex nanoparticles as delivery vehicles of curcumin","volume":"342","author":"Jiang","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2026.115061_b0175","unstructured":"Claritin (Loratadine) Child Dosage Chart | St. Louis Children\u2019s Hospital, (n.d.). https:\/\/www.stlouischildrens.org\/health-resources\/dosage-tables\/loratadine-claritin-dosage-table (Accessed July 8, 2024)."},{"key":"10.1016\/j.ejpb.2026.115061_b0180","unstructured":"2.9.31. Particle size analysis... - European Pharmacopoeia 11.6, (n.d.). https:\/\/pheur.edqm.eu\/app\/11-6\/content\/11-6\/20931E.htm?highlight=on&terms%5B%5D=particle&terms%5B%5D=particle-size&terms%5B%5D=particle%20size&terms%5B%5D=size (accessed May 7, 2025)."},{"key":"10.1016\/j.ejpb.2026.115061_b0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.powtec.2017.12.021","article-title":"Functionality and performance evaluation of directly compressible co-processed excipients based on dynamic compaction analysis and percolation theory","volume":"326","author":"Dra\u0161kovi\u0107","year":"2018","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114623","article-title":"A novel directly compressible co-processed excipient, based-on rice starch for extended-release of tablets","volume":"208","author":"Trisopon","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0195","unstructured":"2.9.1. Disintegration of table... - European Pharmacopoeia 11.6, (n.d.). https:\/\/pheur.edqm.eu\/app\/11-6\/content\/11-6\/20901E.htm?highlight=on&terms%5B%5D=disintegration (Accessed April 2, 2025)."},{"key":"10.1016\/j.ejpb.2026.115061_b0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpba.2018.01.040","article-title":"Assessment of oral formulation-dependent characteristics of orodispersible tablets using texture profiles and multivariate data analysis","volume":"152","author":"Casian","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2026.115061_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106801","article-title":"Testing the disintegration and texture-related palatability predictions for orodispersible tablets using an instrumental tool coupled with multivariate analysis: Focus on process variables and analysis settings","volume":"198","author":"Iovanov","year":"2024","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ejpb.2026.115061_b0210","doi-asserted-by":"crossref","unstructured":"S. Iurian, I. Tomuta, C. Bogdan, L. Rus, T. Tokes, L. Barbu-Tudoran, M. Achim, M. Moldovan, S. Leucuta, Defining the design space for freeze-dried orodispersible tablets with meloxicam, doi: 10.1080\/03639045.2016.1188108 42 (2016) 1977\u20131989. Doi: 10.1080\/03639045.2016.1188108.","DOI":"10.1080\/03639045.2016.1188108"},{"key":"10.1016\/j.ejpb.2026.115061_b0215","unstructured":"2.9.45. Wettability of porous solids including powders - European Pharmacopoeia 11.5, (n.d.). https:\/\/pheur.edqm.eu\/app\/11-5\/content\/11-5\/20945E.htm?highlight=on&terms=wettability (Accessed June 4, 2024)."},{"key":"10.1016\/j.ejpb.2026.115061_b0220","unstructured":"WHO paediatric quality product profile assessment tool, (n.d.). https:\/\/www.who.int\/publications\/m\/item\/who-paediatric-quality-product-profile-assessment-tool (Accessed December 12, 2025)."},{"key":"10.1016\/j.ejpb.2026.115061_b0225","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3390\/pharmaceutics14030516","article-title":"Creating acceptable tablets 3D (CAT 3D): a feasibility study to evaluate the acceptability of 3D printed tablets in children and young people","volume":"14","author":"Bracken","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0230","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpb.2021.06.007","article-title":"Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: a randomized controlled trial","volume":"166","author":"M\u00fcnch","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0235","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/jphp.12610","article-title":"Evidence of acceptability of oral paediatric medicines: a review","volume":"69","author":"Mistry","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115061_b0240","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA), Ondansetron 4 mg Orodispersible Tablets - Summary of Product Characteristics, (n.d.). https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/ce89474eb59a9493f38784093d4c0e094e4fea7e (Accessed February 12, 2026)."},{"key":"10.1016\/j.ejpb.2026.115061_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122493","article-title":"Downstream processing of amorphous solid dispersions into orodispersible tablets","volume":"631","author":"Kokott","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0250","unstructured":"2.9.5. Uniformity of mass of s... - European Pharmacopoeia 11.6, (n.d.). https:\/\/pheur.edqm.eu\/app\/11-6\/content\/11-6\/20905E.htm (Accessed May 7, 2025)."},{"key":"10.1016\/j.ejpb.2026.115061_b0255","unstructured":"2.9.6. Uniformity of content o... - European Pharmacopoeia 11.6, (n.d.). https:\/\/pheur.edqm.eu\/app\/11-6\/content\/11-6\/20906E.htm (Accessed May 7, 2025)."},{"key":"10.1016\/j.ejpb.2026.115061_b0260","unstructured":"Tablets - European Pharmacopoeia 11.6, (n.d.). https:\/\/pheur.edqm.eu\/app\/11-6\/content\/default\/0478E.htm (accessed June 23, 2025)."},{"key":"10.1016\/j.ejpb.2026.115061_b0265","unstructured":"2.9.7. Friability of uncoated ... - European Pharmacopoeia 11.6, (n.d.). https:\/\/pheur.edqm.eu\/app\/11-6\/content\/11-6\/20907E.htm?highlight=on&terms%5B%5D=2.9.7 (Accessed May 13, 2025)."},{"key":"10.1016\/j.ejpb.2026.115061_b0270","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"1807","article-title":"Freeze drying","author":"Pikal","year":"2007"},{"key":"10.1016\/j.ejpb.2026.115061_b0275","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.xphs.2016.05.016","article-title":"Using texture analysis technique to assess the freeze-dried cakes in vials","volume":"105","author":"Hackl","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115061_b0280","doi-asserted-by":"crossref","first-page":"279","DOI":"10.31925\/farmacia.2021.2.13","article-title":"Design of experiments approach to assess the impact of API particle size on freeze-dried bulking agents","volume":"69","author":"\u0218tefana Suciu","year":"2021","journal-title":"Farmacia"},{"key":"10.1016\/j.ejpb.2026.115061_b0285","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1208\/s12249-010-9423-y","article-title":"Maltodextrin: a novel excipient used in sugar-based orally disintegrating tablets and phase transition process","volume":"11","author":"Elnaggar","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115061_b0290","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/pharmaceutics13101526","article-title":"A screening study for the development of simvastatin-doxorubicin liposomes, a co-formulation with future perspectives in colon cancer therapy","volume":"13","author":"Barb\u0103lat\u0103","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0295","doi-asserted-by":"crossref","first-page":"999","DOI":"10.31925\/farmacia.2020.6.6","article-title":"The evaluation of dynamic compaction analysis as a QbD tool for paediatric orodispersible minitablet formulation","volume":"68","author":"Iurian","year":"2020","journal-title":"Farmacia"},{"key":"10.1016\/j.ejpb.2026.115061_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132934","article-title":"Fabrication of edible solid lipid nanoparticle from beeswax\/propolis wax by spontaneous emulsification: optimization, characterization and stability","volume":"387","author":"Shirvani","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.ejpb.2026.115061_b0305","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/cjce.23914","article-title":"Experimental methods in chemical engineering: zeta potential","volume":"99","author":"Lunardi","year":"2021","journal-title":"Can. J. Chem. Eng."},{"key":"10.1016\/j.ejpb.2026.115061_b0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jddst.2019.01.019","article-title":"Maltodextrins as drying auxiliary agent for the preparation of easily resuspendable nanoparticles","volume":"50","author":"Magri","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0315","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/pharmaceutics14020332","article-title":"Influence of the dispersion medium and cryoprotectants on the physico-chemical features of gliadin- and zein-based nanoparticles","volume":"14","author":"Voci","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0320","doi-asserted-by":"crossref","first-page":"798","DOI":"10.31925\/farmacia.2018.5.9","article-title":"Application of the quality by design concept in the development of quercetin-loaded polymeric nanoparticles","volume":"66","author":"Tefas","year":"2018","journal-title":"Farmacia"},{"key":"10.1016\/j.ejpb.2026.115061_b0325","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s11483-024-09884-0","article-title":"Enhanced stability and functionality of freeze-dried encapsulated black cardamom (amomum subulatum) oleoresin: a comprehensive physicochemical and thermal analysis","volume":"19","author":"Sakkaravarthy","year":"2024","journal-title":"Food Biophys."},{"key":"10.1016\/j.ejpb.2026.115061_b0330","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1208\/s12249-013-0008-4","article-title":"Effect of particle size on in-die and out-of-die compaction behavior of ranitidine hydrochloride polymorphs","volume":"14","author":"Khomane","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115061_b0335","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.powtec.2021.03.063","article-title":"Impact of co-processed excipient particles solidity and circularity on critical quality attributes of orodispersible minitablets","volume":"387","author":"Hejduk","year":"2021","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106035","article-title":"Study of rheological and tableting properties of lubricated mixtures of co-processed dry binders for orally disintegrating tablets","volume":"168","author":"Tranov\u00e1","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115061_b0345","doi-asserted-by":"crossref","unstructured":"A.B. Eldin, Near Infra Red Spectroscopy, in: I. Akyar (Ed.), Wide Spectra of Quality Control, IntechOpen, 2011: pp. 237\u2013248. doi: 10.5772\/24208.","DOI":"10.5772\/24208"},{"key":"10.1016\/j.ejpb.2026.115061_b0350","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/pharmaceutics12010060","article-title":"Zein Beta-Cyclodextrin Micropowders for Iron Bisglycinate delivery","volume":"12","author":"Esposito","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115061_b0355","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1255\/jnirs.17","article-title":"Near infrared calibrations for goat\u2019s milk components: protein, total casein, \u03b1s-, \u03b2- and k-caseins, fat and lactose","volume":"1","author":"D\u00edaz-Carrillo","year":"1993","journal-title":"J. near Infrared Spectrosc."},{"key":"10.1016\/j.ejpb.2026.115061_b0360","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/jps.21633","article-title":"In-line and real-time process monitoring of a freeze drying process using Raman and NIR spectroscopy as complementary process analytical technology (PAT) tools","volume":"98","author":"De Beer","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115061_b0365","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpba.2014.04.010","article-title":"NIR spectroscopy for the in-line monitoring of a multicomponent formulation during the entire freeze-drying process","volume":"97","author":"Rosas","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2026.115061_b0370","doi-asserted-by":"crossref","unstructured":"\u30081062\u3009 Tablet Compression Characterization, United States Pharmacopoeia (n.d.). doi: 10.31003\/USPNF_M99395_02_01.","DOI":"10.31003\/USPNF_M99395_02_01"},{"key":"10.1016\/j.ejpb.2026.115061_b0375","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.powtec.2015.04.004","article-title":"Dependence of ejection force on tableting speed\u2014a compaction simulation study","volume":"279","author":"Sun","year":"2015","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0380","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpb.2020.12.021","article-title":"Best practices for selection of excipients for paediatrics \u2013 workshop reflection","volume":"160","author":"Salunke","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0385","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejpb.2011.02.005","article-title":"Orally disintegrating mini-tablets (ODMTs) \u2013 a novel solid oral dosage form for paediatric use","volume":"78","author":"Stoltenberg","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0390","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0378-5173(98)00389-5","article-title":"Effect of magnesium stearate on bonding and porosity expansion of tablets produced from materials with different consolidation properties","volume":"179","author":"Zuurman","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0395","article-title":"Effect of lubricants on the properties of tablets compressed from varied size granules","volume":"8","author":"Hackl","year":"2023","journal-title":"Brit. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0400","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejpb.2022.08.023","article-title":"Impact of lubrication on key properties of orodispersible minitablets in comparison to conventionally sized orodispersible tablets","volume":"180","author":"Kuck","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115061_b0405","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1248\/bpb.27.1630","article-title":"Classification of loratadine based on the biopharmaceutics drug classification concept and possible in vitro-in vivo correlation","volume":"27","author":"Zahirul","year":"2004","journal-title":"Biol. Pharm. Bull"},{"key":"10.1016\/j.ejpb.2026.115061_b0410","article-title":"Production of high loading insulin nanoparticles suitable for oral delivery by spray drying and freeze drying techniques","volume":"12","author":"Guo","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.115061_b0415","doi-asserted-by":"crossref","DOI":"10.1002\/pat.70235","article-title":"Preparation and characterization of anastrozole nanocrystal fast dissolving tablets using super disintegrants and co-processed excipients for enhanced drug release","volume":"36","author":"Akbar","year":"2025","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0420","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/10837450.2019.1579228","article-title":"Application of a quality-by-design approach for utilizing sodium stearyl fumarate as a taste-masking agent in dextromethorphan hydrobromide orally disintegrating tablets","volume":"24","author":"Mahrous","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2026.115061_b0425","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-021-00770-2","article-title":"Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics","volume":"19","author":"Guo","year":"2021","journal-title":"J. Nanobiotechnol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:21:28Z","timestamp":1782822088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":85,"alternative-id":["S0939641126000822"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115061","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orodispersible tablets as delivery platform for oral administration of drug-loaded nanoparticles to paediatric patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115061"}}